Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Similar to the Guideline of today, but without gross pathology and without GLP.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1978
Report date:
1978

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
no
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
2,2-dimethylpropane-1,3-diyl dibenzoate
EC Number:
224-081-9
EC Name:
2,2-dimethylpropane-1,3-diyl dibenzoate
Cas Number:
4196-89-8
Molecular formula:
C19H20O4
IUPAC Name:
3-(benzoyloxy)-2,2-dimethylpropyl benzoate
Specific details on test material used for the study:
- yellowish white chunks

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 200-244 g
- Fasting period before study: diet was withheld for up to 18 hours before doseing
- Housing: in groups of 5
- Diet ad libitum
- Water ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- temperature and humidity controlled quarters
- The animals were maintained in accordance with the recommendations contained in H.E.W. Publication No.74-23 (N.I.H.) entitled "Guide for the care and use of laboratory animals"

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on oral exposure:
The test material was administered orally by gavage as a suspension in corn oil. The dosage was administered at a volume of 20 ml/kg.
Doses:
5000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
5 males and 5 females were used in this study. The test material was administered orally by gavage as a suspension in corn oil. The dosage level was administered at a volume of 20 mg/kg. Observations for toxic signs were recorded during the first 4 hours following dosing, at 24 hours and daily thereafter for a total of 14 days. The rats were observed for mortality, clinical signs and body weight development.
Statistics:
no data

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Remarks on result:
other: No rat died. All rats showed weight gain. Some rats developed hypoactivity, urine stained abdomen and diarrhea, but returned to normal within the 14 day observation period.
Mortality:
No rat died.
Clinical signs:
other: Some rats developed hypoactivity, urine stained abdomen and diarrhea, but returned to normal within the 14 day observation period.
Gross pathology:
no data

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Five male and 5 female Sprague-Dawley rats received a single dose of 5000 mg/kg bw. The rats were observed for mortality, clinical signs and body weight development. No rat died. The discriminating dose is 5000 mg/kg bw.
Executive summary:

5 male and 5 female Sprague-Dawley rats were used to examine the acute oral toxicity in a study similar to the Guideline of today. There is no information on GLP and or gross pathology. 5000mg/kg bw of the test material was administered orally by gavage as a suspension in corn oil. The dosage level was administered at a volume of 20 ml/kg. Observations for pharmacotoxic signs were recorded during the first 4 hours following dosing, at 24 hours and daily thereafter for a total of 14 days. The rats were observed for mortality, clinical signs and body weight development. No rat died. All rats showed weight gain. Some rats developed hypoactivity, urine stained abdomen and diarrhea, but returned to normal within the 14 day observation period. Thus, the LD50 is > 5000 mg/kg bw.